Trulieve Cannabis (OTCMKTS:TCNNF – Get Free Report) is expected to be releasing its results before the market opens on Friday, August 7th. Analysts expect the company to post earnings of $0.06 per share and revenue of $284.0840 million for the quarter.
Trulieve Cannabis Stock Performance
TCNNF opened at $11.86 on Wednesday. The business’s 50-day moving average is $11.41 and its two-hundred day moving average is $8.63. Trulieve Cannabis has a 1 year low of $3.25 and a 1 year high of $13.28.
Wall Street Analysts Forecast Growth
Separately, Alliance Global Partners reaffirmed a “buy” rating on shares of Trulieve Cannabis in a research report on Thursday, June 4th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy”.
About Trulieve Cannabis
Trulieve Cannabis Corp. is a vertically integrated cannabis operator and retailer, offering a full suite of services from cultivation and processing to distribution and sales. The company develops, manufactures and markets a diverse range of cannabis products under its own brand portfolio, serving both medical and adult-use consumers through a network of branded dispensaries and delivery services.
Trulieve’s product lineup includes dried flower, vape cartridges, concentrates, edibles, tinctures and topicals, all of which are produced in compliance with state regulatory requirements.
Featured Stories
- Five stocks we like better than Trulieve Cannabis
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
